IL17A and COVID-19: Serum concentrations of proinflammatory cytokines and chemokines—including IFN-γ, TNF-α, IP-10, G-CSF, IL-2, IL-6, IL-8, IL-9, IL-10, and IL-17—were increased in patients with severe COVID-19 and strongly correlated with disease outcome (117).